No photo of Sari Jalkanen

Sari Jalkanen

20092011
If you made any changes in Pure these will be visible here soon.

Publications 2009 2011

  • 2 Article
  • 2 Conference article

FlowAnd: Comprehensive Computational Framework for Flow Cytometry Data Analysis

Lahesmaa-Korpinen, A-M. K., Jalkanen, S., Chen, P., Valo, E. A., Nunez-Fontarnau, J., Rantanen, V., Oghabian, A., Vakkila, J. M., Porkka, K., Mustjoki, S. & Hautaniemi, S., 2011, In : Journal of Proteomics and Bioinformatics. 4, 11, p. 245-249

Research output: Contribution to journalArticleScientificpeer-review

Dasatinib Induces a Rapid, Dose-Controllable Mobilization of Cytotoxic Lymphocytes: A Novel Immunomodulatory Effect Associated With Prolonged Therapy Responses In Advanced Leukemia.

Mustjoki, S., Rousselot, P., Jalkanen, S., Kreutzman, A., Melo, T., Lahesmaa, A-M., Hautaniemi, S., Molimard, M., Smykla, R., Lee, F., Vakkila, J. & Porkka, K., 2010, In : Blood. 116, p. 516-517 2 p.

Research output: Contribution to journalConference articleScientificpeer-review

The Proportion of Ph+CD34(+)CD38(neg) Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI-Therapy. Data From a Randomized Phase II NordCML006 Study

Mustjoki, S., Richter, J., Barbany, G., Dybedal, I., Fioretos, T., Gedde-Dahl, T., Gjertsen, B. T., Hovland, R., Jalkanen, S., Josefsen, D., Koskenvesa, P., Lassen, C., Latvala, K., Majeed, W., Malm, C., Markevarn, B., Moshfegh, A., Ohm, L., Olofsson, T., Olsson-Stromberg, U. & 10 othersRapakko, K., Remes, K., Stentoft, J., Stenke, L., Suominen, M., Thunberg, S., Bjerrum, O. W., Simonsson, B., Porkka, K. & Hjorth-Hansen, H., 2010, In : Blood. 116, p. 291-292 2 p.

Research output: Contribution to journalConference articleScientificpeer-review

A novel dasatinib-sensitive RCSD1-ABL1 fusion transcript in chemotherapy-refractory adult pre-B lymphoblastic leukemia with t(1;9)(q24;q34): [Letters to the editor]

Mustjoki, S., Hernesniemi (Jalkanen), S., Rauhala, A., Kähkönen, M., Almqvist, A., Lundan, T. & Porkka, K., 2009, In : Haematologica. 94, 10, p. 1469-1471 3 p.

Research output: Contribution to journalArticleScientificpeer-review